Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27590329)

Published in Ann Surg Oncol on September 02, 2016

Authors

Jon M Gerry1, Thuy B Tran1, Lauren M Postlewait2, Shishir K Maithel2, Jason D Prescott3, Tracy S Wang4, Jason A Glenn4, John E Phay5, Kara Keplinger5, Ryan C Fields6, Linda X Jin6, Sharon M Weber7, Ahmed Salem7, Jason K Sicklick8, Shady Gad8, Adam C Yopp9, John C Mansour9, Quan-Yang Duh10, Natalie Seiser10, Carmen C Solorzano11, Colleen M Kiernan11, Konstantinos I Votanopoulos12, Edward A Levine12, Ioannis Hatzaras13, Rivfka Shenoy13, Timothy M Pawlik3, Jeffrey A Norton1, George A Poultsides14

Author Affiliations

1: Department of Surgery, Stanford University, Stanford, CA, USA.
2: Department of Surgery, Emory University, Atlanta, GA, USA.
3: Department of Surgery, The Johns Hopkins University, Baltimore, MD, USA.
4: Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
5: Department of Surgery, The Ohio State University, Columbus, OH, USA.
6: Department of Surgery, Washington University, St. Louis, MO, USA.
7: Department of Surgery, University of Wisconsin, Madison, WI, USA.
8: Department of Surgery, University of California San Diego, San Diego, CA, USA.
9: Department of Surgery, University of Texas Southwestern, Dallas, TX, USA.
10: Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
11: Department of Surgery, Vanderbilt University, Nashville, TN, USA.
12: Department of Surgery, Wake Forest University, Winston Salem, NC, USA.
13: Department of Surgery, New York University, New York, NY, USA.
14: Department of Surgery, Stanford University, Stanford, CA, USA. gpoultsides@stanford.edu.

Articles cited by this

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg (2001) 2.79

The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67

Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Ann Surg (2012) 2.38

Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer (2008) 2.09

Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer (1981) 1.40

Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer (1979) 1.35

The role of surgery in the management of recurrent adrenocortical carcinoma. J Clin Endocrinol Metab (2012) 1.29

Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol (2009) 1.21

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol (2013) 1.16

Adrenocortical carcinoma: surgical progress or status quo? Arch Surg (2001) 1.14

Regional lymphadenectomy for adrenocortical carcinoma. Ann Surg (2013) 1.11

Adrenocortical tumors in children. J Pediatr Surg (2001) 1.08

Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis. Am Surg (2013) 0.92

Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg (2015) 0.85

Impact of Regional Lymph Node Dissection on Disease Specific Survival in Adrenal Cortical Carcinoma. Horm Metab Res (2015) 0.83

Adrenocortical carcinoma in children: first population-based clinicopathological study with long-term follow-up. Oncol Rep (2014) 0.80

Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study. World J Surg (2016) 0.80

Surgical Management of Adrenocortical Carcinoma: An Evidence-Based Approach. Surg Oncol Clin N Am (2015) 0.79

Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. Ann Surg (2017) 0.77

Articles by these authors

Multiple complications and short length of stay are associated with postoperative readmissions. Am J Surg (2014) 1.69

Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol (2015) 1.40

Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 1.08

Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid (2008) 0.97

Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol (2015) 0.86

Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. Ann Surg Oncol (2015) 0.84

Postdischarge complications are an important predictor of postoperative readmissions. Am J Surg (2014) 0.84

The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB (Oxford) (2016) 0.84

A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol (2016) 0.81

Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. Ann Surg Oncol (2015) 0.80

To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer. Gastric Cancer (2015) 0.80

Techniques of parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught. Am J Surg (2014) 0.79

Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol (2015) 0.77

Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. World J Surg (2016) 0.77

Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) (2016) 0.77

Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis. Ann Surg Oncol (2016) 0.76

Outcomes after resection of cortisol-secreting adrenocortical carcinoma. Am J Surg (2015) 0.75

Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) (2016) 0.75

Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma. J Gastrointest Surg (2015) 0.75

Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. HPB (Oxford) (2016) 0.75

Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) (2016) 0.75

Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients. J Gastrointest Surg (2016) 0.75

Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg (2016) 0.75

Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg (2017) 0.75

Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable? J Gastrointest Surg (2017) 0.75

Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol (2017) 0.75

Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) (2017) 0.75

Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. HPB (Oxford) (2017) 0.75

Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study. Ann Surg Oncol (2016) 0.75

Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy. J Gastrointest Surg (2017) 0.75

Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World J Surg (2017) 0.75

A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. J Gastrointest Surg (2016) 0.75

Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers. Ann Surg Oncol (2020) 0.75

Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study. J Gastrointest Surg (2016) 0.75

Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System. J Gastrointest Surg (2017) 0.75

Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. Ann Surg Oncol (2016) 0.75

Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies. J Gastrointest Surg (2017) 0.75